Loading...

LBRX LB PHARMACEUTICALS INC Management Changes 8-K Filing

LB P

LBRX

LB PHARMACEUTICALS INC

(LBRX)

2025 8-K

Financial Results Released

Director Departure

Management Changes

Stock Offering Details

Lease Expansion Agreement

Management Change

Quarterly Results

External Links:

LB Pharmaceuticals Inc announced the appointment of Kaya Pai Panandiker as Chief Commercial Officer, effective November 10, 2025. She previously held senior roles at Neumora Therapeutics and Cerevel Therapeutics.

AI Assistant

LB PHARMACEUTICALS INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.